P. Andrews

发表

Functional group contributions to drug-receptor interactions.

P. Andrews, D. Craik, J. L. Martín, 1984, Journal of medicinal chemistry.

Transition-state stabilization and enzymic catalysis. Kinetic and molecular orbital studies of the rearrangement of chorismate to prephenate.

P. Andrews, G. Smith, I. Young, 1973, Biochemistry.

β-turn topography

P. Andrews, P. Alewood, J. B. Ball, 1993 .

13C NMR studies of the molecular flexibility of antidepressants.

P. Andrews, D. Craik, D. J. Gale, 1986, Journal of pharmaceutical sciences.

A common structural basis for c.n.s. drug action

P. Andrews, E. J. Lloyd, 1983, The Journal of pharmacy and pharmacology.

Molecular conformation and biological activity of central nervous system active drugs

P. Andrews, P. R. Andrews, E. J. Lloyd, 1982, Medicinal research reviews.

Design of transition-state analogues for gaba-transaminase

P. Andrews, D. Winkler, G. Jones, 2009 .

Conformational analysis of flexible antidepressant drugs

P. Andrews, D. Craik, S. Munro, 1987 .

A Pharmacophore Hypothesis for Antidepressant Activity

P. Andrews, D. Craik, S. Munro, 1987 .

Common structural features of drugs, transmitters and peptides in the central nervous system.

P. Andrews, E. J. Lloyd, 1986, Progress in medicinal chemistry.

MOLECULAR CONFORMATION AND BIOLOGICAL ACTIVITY OF CENTRAL NERVOUS SYSTEM ACTIVE DRUGS

P. Andrews, E. J. Lloyd, 1983 .

Molecular orbital calculations on anticonvulsant drugs.

P. Andrews, 1969, Journal of medicinal chemistry.

Association of CNS active drugs with 9-ethyladenine.

P. Andrews, A. Buchanan, 1971, Biochemical pharmacology.

Convulsant, anticonvulsant and anaesthetic barbiturates. 5-Ethyl-5-(3'-methyl-but-2'-enyl)-barbituric acid and related compounds.

P. Andrews, D. Lodge, G. Jones, 1979, European journal of pharmacology.

Conformational analysis of muscimol, a GABA agonist.

P. Andrews, G. Johnston, 1979, Journal of theoretical biology.

Convulsant and anticonvulsant barbiturates. 1. Molecular conformations from classical potential-energy calculations.

P. Andrews, G. Jones, 1980, Journal of medicinal chemistry.

Conformations of barbiturates related to pentobarbitone. I. Crystal structure oftrans-5-ethyl-5-but-1′-enyl barbituric acid

P. Andrews, G. Jones, 1981 .

Evaluation of MINDO/3 calculations in simple amides, ureas, and heterocycles of biological interest

P. Andrews, J. Defina, 1980 .

The use of sedimentation coefficients to distinguish between models for protein oligomers.

P. Andrews, P. Jeffrey, 1976, Biophysical chemistry.

20 – THE ROLE OF FUNCTIONAL GROUPS IN DRUG–RECEPTOR INTERACTIONS

P. Andrews, 2003 .

Rearrangement of chorismate to prephenate. Use of chorismate mutase inhibitors to define the transition state structure.

P. Andrews, E. Rizzardo, G. Smith, 1977, Biochemistry.

Convulsant, anticonvulsant and anaesthetic barbiturates. In vivo activities of oxo- and thiobarbiturates related to pentobarbitone.

P. Andrews, G. Jones, D. Poulton, 1982, European journal of pharmacology.

Binding of CNS active drugs to the peptide bond: a model system and mode of action hypothesis.

P. Andrews, 1972, Journal of pharmaceutical sciences.

13C NMR studies of insulin. Part I—Spectral assignments

P. Andrews, D. Craik, K. A. Higgins, 1989, Magnetic resonance in chemistry : MRC.

A one-variable topographical description for ß-turns

P. Andrews, P. Alewood, J. B. Ball, 1991 .

Novel ω-Conotoxins from Conus catus Discriminate among Neuronal Calcium Channel Subtypes*

P. Andrews, D. Craik, David John Adams, 2000, The Journal of Biological Chemistry.

Structural and conformational analogy between cholecystokinin and ergopeptines

P. Andrews, R. Hughes, 1987, The Journal of pharmacy and pharmacology.

Conformation-activity relationships of opiate analgesics

Jennifer Martin, Peter Andrews, P. Andrews, 1987, J. Comput. Aided Mol. Des..

Conformational analysis of folates and folate analogues

P. Andrews, D. Winkler, M. Spark, 2009 .

Conformational analysis of the ergot alkaloids ergotamine and ergotaminine.

P. Andrews, D. Winkler, I. Rae, 1982, Journal of medicinal chemistry.

Calculated sedimentation ratios for assemblies of two, three, four, and five spatially equivalent protomers.

P. Andrews, P. Jeffrey, 1980, Biophysical chemistry.

GABA agonists and antagonists.

P. Andrews, P R Andrews, G. Johnston, 1979, Biochemical pharmacology.

Aspartate aminotransferase: investigation of the active sites.

P. Andrews, T. Nero, S. W. Oliver, 1990, Journal of molecular graphics.

Carboxyl-modified amino acids and peptides as protease inhibitors.

P. Andrews, R. Hanzlik, S. Thompson, 1986, Journal of medicinal chemistry.

Molecular orbital studies of reaction mechanism and transition state structures for GABA-transaminase

P. Andrews, D. Winkler, M. Iskander, 1988 .

Stereochemistry and Electronic structure of anticonvulsant drugs

P. Andrews, J. Defina, 2009 .

Topological side-chain classification of β-turns: Ideal motifs for peptidomimetic development

Jim McKie, Tran Trung Tran, Mark L. Smythe, 2005, J. Comput. Aided Mol. Des..

Conformational analysis of picrotoxinin by N.M.R., X-ray crystallography, and molecular orbital and classical potential-energy calculations

David A. Winkler, Robert T. C. Brownlee, Pr Andrews, 1983 .

Geometries of functional group interactions in enzyme-ligand complexes: Guides for receptor modelling

Marina Tintelnot, Peter R. Andrews, P. Andrews, 1989, J. Comput. Aided Mol. Des..

Structural specificity of barbiturates and related drugs.

P. Andrews, L. C. Mark, 1982, Anesthesiology.

Theoretical and spectroscopic studies of anticonvulsant drugs

P. Andrews, 1969 .

Location of multiparticle-multihole strength in 16N via the 3-particle transfer reaction 13C(α, p)16N at 118 MeV

P. Andrews, H. Nann, A. Bacher, 1986 .

The 13C(p̄, d)12C reaction at 119 MeV

P. Andrews, B. Spicer, V. Officer, 1987 .

Spectroscopy of 14C from the 11B(α,p)14C reaction at 118 MeV

P. Andrews, H. Nann, A. Bacher, 1987 .

Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.

D. Manallack, P. Andrews, M. Costa, 1988, Molecular pharmacology.

Conformational analysis of clinically active anticonvulsant drugs.

P. Andrews, M. Wong, J. Defina, 1986, Journal of medicinal chemistry.

A common structural model for central nervous system drugs and their receptors.

P. Andrews, P R Andrews, E. J. Lloyd, 1986, Journal of medicinal chemistry.

Conformational analysis of convulsant and anticonvulsant barbiturates

P. Andrews, G. Jones, 2009 .

FUNCTIONAL GROUP CONTRIBUTIONS TO DRUG-RECEPTOR INTERACTIONS

David J. Craik, Peter R. Andrews, P. Andrews, 1985 .

Verification of the interaction between peptide T and CD4 using surface plasmon resonance

P. Andrews, E. Nice, T. Ramsdale, 1993, FEBS letters.

Conformational energy calculations and electrostatic potentials of dihydrofolate reductase ligands: relevance to mode of binding and species specificity.

P. Andrews, D. Winkler, M. Sadek, 1986, Journal of medicinal chemistry.

Anisatin: a Crystallographic, N.M.R. and Theoretical Conformation Study

J. Gulbis, P. Andrews, D. Craik, 1988 .

Functional groups, drug-receptor interactions and drug design

Peter R. Andrews, P. Andrews, 1986 .

Actions of pentobarbitone and derivatives with modified 5-butyl substituents on GABA and diazepam binding to rat brain synaptosomal membranes

P. Andrews, G. Nicholson, J. Skerritt, 1983, Neurochemical Research.

Direct excitant action of convulsant barbiturates

P. Andrews, M. Willow, G. Johnston, 1981, Experientia.

Conformational analysis and active site modelling of angiotensin-converting enzyme inhibitors.

R Woods, P. Andrews, P R Andrews, 1985, Journal of medicinal chemistry.

A common active site model for catalysis by chorismate mutase--prephenate dehydrogenase.

P. Andrews, E. Heyde, 1979, Journal of Theoretical Biology.

Molecular Modelling of the Active Site of Enkephalin-Degrading Neutral Endopeptidase-24.11 (Enkephalinase) An Active Site Model for Neutral Endopeptidase-24.11

P. Andrews, J. Reiss, M. Iskander, 1988 .

The structure and properties of CH2NO radical from molecular orbital calculations

P. Andrews, 1970 .

Stereospecific Actions of GABA Analogues

P. Andrews, R. Allan, B. Twitchin, 1979 .

Cis-trans isomerization of the proline residue in insulin studied by 13C NMR spectroscopy.

P. Andrews, D. Craik, J. Hall, 1988, Drug design and delivery.

Structure–activity relations and receptor modelling of convulsant and anticonvulsant barbiturates from crystallographic data

P. Andrews, G. Jones, 1987 .